𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study

✍ Scribed by F. Thalhammer; K. Geissler; U. Jäger; P. A. Kyrle; I. Pabinger; M. Mitterbauer; H. Gisslinger; P. Knöbl; K. Laczika; B. Schneider; O. A. Haas; K. Lechner

Publisher
Springer
Year
1996
Tongue
English
Weight
191 KB
Volume
72
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of complete remission in a pat
Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine
✍ A. Kuendgen; T. Gräf; F. Zohren; B. Hildebrandt; A. Hünerlitürkoglu; N. Gatterma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 654 KB

For patients with acute myeloid leukemia refractory to intensive chemotherapy prognosis is very poor and treatment options are limited. 5-Azacytidine, a demethylating drug, is effective in the treatment of myelodysplastic syndromes when administered at a low-dose, subcutaneously. We report a case of

Predictors of response to reinduction ch
Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy
✍ Joseph M. Brandwein; Vikas Gupta; Andre C. Schuh; Aaron D. Schimmer; Karen Yee; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

## Abstract Eighty‐one patients with acute myeloid leukemia who had persistent leukemia following standard induction therapy with cytarabine plus daunorubicin (7+3 regimen) underwent reinduction therapy with a combination of mitoxantrone, etoposide, and high‐dose cytarabine (HiDAC). Patients achiev